GlassScriptPhysician profile
Ingrid Paredes
NPI 1316307374
$65,486.33
in general payments reported to CMS, 2019-2025
33 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $737 · 2020: $210 · 2021: $546 · 2022: $13K · 2023: $18K · 2024: $18K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Food and Beverage: $4,143 · Travel and Lodging: $2,135 · Education: $64.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,326.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,560.00 |
| Food and Beverage | $4,142.82 |
| Travel and Lodging | $2,135.00 |
| Education | $64.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $33,660.34 | 2022-2025 | Zurzuvae |
| Exeltis, USA INC. | $17,672.64 | 2019-2024 | Slynd, Nuvessa |
| Intuitive Surgical, INC. | $9,791.53 | 2022-2023 | Da Vinci Surgical System |
| Conmed Corporation | $660.15 | 2022-2025 | Airseal |
| Abbvie INC. | $496.70 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $465.24 | 2021-2025 | |
| Astellas Pharma US INC | $335.27 | 2023-2025 | Veozah, Myrbetriq |
| Davol INC. | $301.28 | 2023-2024 | Phasix Mesh |
| Novo Nordisk INC | $299.27 | 2023-2025 | Wegovy |
| Hologic Sales and Service, LLC | $262.67 | 2022-2024 | Acessa Provu System, Thinprep 2000 Processor, Aptima |
| Sage Therapeutics, LLC | $175.22 | 2020-2023 | |
| Myriad Women'S Health, INC. | $173.31 | 2023 | Myrisk |
| Phathom Pharmaceuticals, INC. | $164.48 | 2025 | Voquezna |
| Sumitomo Pharma America, INC. | $131.71 | 2023-2025 | Myfembree, Gemtesa |
| Myovant Sciences INC. | $127.62 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $124.99 | 2021 | |
| Evofem Biosciences, INC. | $76.71 | 2021-2025 | Phexxi, Solosec, Phexx |
| Bayer Healthcare Pharmaceuticals INC. | $74.79 | 2021-2025 | |
| Gynesonics, INC. | $74.69 | 2021 | |
| Lilly USA, LLC | $60.87 | 2024-2025 | Zepbound, Mounjaro |
| Therapeuticsmd, INC. | $60.38 | 2019-2021 | |
| Pfizer INC. | $49.49 | 2022-2024 | |
| Organon LLC | $34.92 | 2023 | Nexplanon |
| Coopersurgical, INC. | $34.82 | 2024-2025 | Paragard T 380a |
| Zyla Life Sciences, INC. | $27.70 | 2020 | |
| Cepheid | $25.37 | 2025 | Genexpert |
| Kerecis Limited | $22.65 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Optumhealth Care Solutions, LLC | $21.28 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Lupin INC. | $19.03 | 2021 | |
| Merck Sharp & Dohme LLC | $17.06 | 2022 | |
| Duchesnay USA Incorporated | $15.58 | 2019 | |
| Meditrina | $15.07 | 2025 | |
| Alydia Health | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Paredes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.